Skip to Main Content

Paper Details

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.
Mol Ther
11
2023
Author NameAffiliation
Ladan FazliUniversity of British Columbia
Martin E GleaveUniversity of British Columbia
  • 1 - 2

Datasets

Release 1.2